5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | NEUTRAL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.90▼ | 1.92▼ | 1.93▼ | 1.97▼ | 2.21▼ |
MA10 | 1.91▼ | 1.94▼ | 1.94▼ | 2.12▼ | 1.89▼ |
MA20 | 1.92▼ | 1.95▼ | 2.00▼ | 2.26▼ | 1.73▲ |
MA50 | 1.95▼ | 1.97▼ | 2.06▼ | 1.88▲ | 1.48▲ |
MA100 | 1.95▼ | 2.08▼ | 2.29▼ | 1.74▲ | 1.89▼ |
MA200 | 2.00▼ | 2.29▼ | 2.25▼ | 1.52▲ | 2.35▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.002▼ | -0.004▼ | -0.003▼ | -0.088▼ | 0.061▲ |
RSI | 32.158▼ | 38.199▼ | 38.404▼ | 41.923▼ | 53.269▲ |
STOCH | 20.833 | 30.559 | 39.101 | 15.570▼ | 56.367 |
WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -89.818▼ | -59.551 |
CCI | -212.593▼ | -145.606▼ | -159.049▼ | -99.804 | 25.942 |
Saturday, February 20, 2021 11:29 PM
AcelRx Pharmaceuticals (NASDAQ:ACRX) was downgraded by Zacks Investment Research from a “hold” rating to a “strong sell” rating in a note issued to investors on Friday, Zacks.com reports. According to ...
|
Thursday, February 18, 2021 06:49 PM
Pomerantz LLP is investigating claims on behalf of investors of AcelRx Pharmaceuticals, Inc. ("AcelRx" or the "Company") (NASDAQ: ACRX). Such investors are advised to contact Robert S. Willoughby at ...
|
Wednesday, February 17, 2021 05:30 AM
AcelRx Pharmaceuticals, Inc.,, a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in healthcare institutions, today announced an ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
26/02/21 | 1.89 | 2.01 | 1.87 | 1.88 | 2,575,565 |
25/02/21 | 2.03 | 2.055 | 1.9117 | 1.94 | 2,808,208 |
24/02/21 | 2.0022 | 2.16 | 1.98 | 2.08 | 2,967,572 |
23/02/21 | 1.9109 | 1.98 | 1.76 | 1.89 | 4,718,298 |
22/02/21 | 2.16 | 2.2186 | 2.06 | 2.07 | 3,082,382 |
19/02/21 | 2.2029 | 2.24 | 2.13 | 2.16 | 2,710,699 |
18/02/21 | 2.23 | 2.28 | 2.10 | 2.16 | 3,217,918 |
17/02/21 | 2.35 | 2.35 | 2.22 | 2.23 | 2,920,607 |
16/02/21 | 2.49 | 2.52 | 2.11 | 2.30 | 10,633,411 |
12/02/21 | 2.59 | 2.5906 | 2.47 | 2.51 | 2,607,796 |
|
|
||||
|
|
||||
|
|